BAX News and Press, Baxter International Inc. From 05/02/24

2024-05-02 10:45:38 ET Baxter International Inc. (BAX) Q1 2024 Earnings Conference Call May 02, 2024 08:30 AM ET Company Participants Clare Trachtman - Vice President, Investor Relations Joe Almeida - Chairman & Chief Executive Officer Joel Grade - Executive ...

2024-05-02 07:19:27 ET More on Baxter Baxter International Inc. Is A Buy (Technical Analysis) Broyhill - Baxter International: Renal Care Spin-Off And Recent Revamp Should Provide Catalysts Baxter: Market-Leading Medical Supplier With Lots In The Pipeline Bax...

First-quarter sales from continuing operations of $3.59 billion increased 2% on a reported basis and 3% on a constant currency basis, exceeding the company’s previously issued guidance 1 First-quarter U.S. GAAP 2 diluted earnings per share (EPS) from continuing operations w...

Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...

2024-05-01 11:33:49 ET More on Baxter Baxter International Inc. Is A Buy (Technical Analysis) Broyhill - Baxter International: Renal Care Spin-Off And Recent Revamp Should Provide Catalysts Baxter: Market-Leading Medical Supplier With Lots In The Pipeline Bax...

2024-04-23 13:46:11 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s been a month since Boeing (NYSE: BA ) CEO Dave Calhoun announced that he would step down at the end of 2024. While his departure wasn’t termed a “f...

2024-04-22 13:00:00 ET Summary Rob Isbitts discusses navigating market risk and why the easy money era is over. Investors need to focus on both offense and defense in their portfolio strategy. Options can be a useful tool for retail investors to protect their portfolios. ...

2024-04-11 09:09:08 ET More on Baxter Baxter International Inc. Is A Buy (Technical Analysis) Broyhill - Baxter International: Renal Care Spin-Off And Recent Revamp Should Provide Catalysts Baxter: Market-Leading Medical Supplier With Lots In The Pipeline Nov...

Five new launches reinforce Baxter’s focus on differentiated products and enhance the company’s Pharmaceuticals portfolio in critical therapeutic areas Products feature ready-to-use formulations to help support patient safety and offer added convenience for healthcare profession...

Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2024 financial results on Thursday, May 2, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q...